Iohexol-lnduced Neutrophil Myeloperoxidase Release and Activation Upon Contact with Vascular Stent-Graft Material: A Mechanism Contributing to the Postimplantation Syndrome?

Journal of Endovascular Therapy

Volumn 10, Issue 5, 2003, Pages 958-967

  Videm, Vibeke ^a,b   Ødegård, Asbjørn ^b   Myhre, Hans Olav ^b  

^a Institute of Laboratory Medicine   (Norway)

^b TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

Author keywords

Contrast media; Inflammation; Iohexol; Neutrophil activation; Stent graft

Indexed keywords

ANTICOAGULANT AGENT; COMPLEMENT; CONTRAST MEDIUM; EDETIC ACID; HEPARIN; IOHEXOL; LACTOFERRIN; LEPIRUDIN; MYELOPEROXIDASE; NITINOL; POLYETHYLENE; STENT GRAFT MATERIAL; UNCLASSIFIED DRUG; PEROXIDASE;

ANGIOGRAPHY; ARTICLE; CATHETER; CELL CULTURE; CELL ISOLATION; COMPLEMENT ACTIVATION; CONTROLLED STUDY; DEGRANULATION; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG MECHANISM; DRUG POTENTIATION; ENZYME IMMUNOASSAY; ENZYME RELEASE; HUMAN; HUMAN CELL; IMPLANT; IMPLANTATION; IN VITRO STUDY; INFLAMMATION; LEUKOCYTE ACTIVATION; NEUTROPHIL DEGRANULATION; POSTIMPLANTATION SYNDROME; PRIORITY JOURNAL; STENT; SYNDROME DELINEATION; VASCULAR STENT; BLOOD VESSEL PROSTHESIS; DRUG EFFECT; ENZYMOLOGY; METABOLISM; NEUTROPHIL; POSTOPERATIVE COMPLICATION; SYNDROME;

BLOOD VESSEL PROSTHESIS; CELL DEGRANULATION; CONTRAST MEDIA; HUMANS; IOHEXOL; NEUTROPHIL ACTIVATION; NEUTROPHILS; PEROXIDASE; POSTOPERATIVE COMPLICATIONS; STENTS; SYNDROME;

EID: 0346103798     PISSN: 15266028     EISSN: None     Source Type: Journal    
DOI: 10.1583/1545-1550(2003)010<0958:INMRAA>2.0.CO;2     Document Type: Article

References (21)

1. Lillevang ST, Albertsen M, Rasmussen F, et al. Effect of radiographic contrast media on granulocyte phagocytosis of Escherichia coli in a whole blood flow cytometric assay. Invest Radiol. 1994;29:68-71.
2. Rasmussen F, Georgsen J, Antonsen S, et al. Phagocytic properties of granulocytes after intravenous injection of ioxaglate or iohexol. Acta Radiol. 1992;33:271-274.
3. Farrow R, Roobottom CA, Wells IP, et al. Effects of radiographic contrast media on leukocyte phagocytosis. Acta Radiol. 1994;1:249-252.
4. Georgsen J, Rasmussen F, Pedersen JO. Granulocyte chemotaxis. Influence of radiographic contrast media on the chemoattractive properties of serum. Acta Radiol. 1990;31:531-536.
5. Georgsen J, Rasmussen F, Pedersen JO. The effect of radiographic contrast media on the chemotaxis of granulocytes. Invest Radiol. 1988;23:621-626.
6. Rasmussen F, Antonsen S, Georgsen J, et al. Granulocyte adherence after intravenous and intraarterial injection of ioxaglate or iohexol. Acta Radiol. 1992;33:490-494.
7. Georgsen J, Rasmussen F, Antonsen S, et al. Influence of radiographic contrast media on granulocyte enzymes and complement during uncomplicated urographies. EurJ Radiol. 1991;12:63-66.
8. Rasmussen F, Antonsen S, Georgsen J. Granulocyte adherence is inhibited by radiographic contrast media in vitro. Acta Radiol. 1992;33:379-383.
9. Rasmussen F, Antonsen S, Georgsen J, et al. Radiographic contrast media and release of neutrophil specific proteins in vitro and after intravenous injection. Acta Radiol. 1992;33:495-499.
10. Blann AD, Adams R, Ashleigh R, et al. Changes in endothelial, leucocyte and platelet markers following contrast medium injection during angiography in patients with peripheral artery disease. Br J Radiol. 2001;74:811-817.
11. Ødegård A, Lundbom J, Myhre HO, et al. The inflammatory response following treatment of abdominal aortic aneurysms: a comparison between open surgery and endovascular repair. Eur J Vasc Endovasc Surg. 2000;19:536-544.
12. Bøyum A. Isolation of mononuclear cells and granulocytes from human blood. Scand J Clin Lab Invest. 1968;21(Suppl 97):77-89.
13. Videm V. Heparin in clinical doses 'primes' granulocytes to subsequent activation as measured by myeloperoxidase release. Scand J Immunol. 1996;43:385-390.
14. Hegnhøj J, Schaffalitzky de Muckadell OB. An enzyme-linked immunosorbent assay for measurement of lactoferrin in duodenal aspirates and other biological fluids. Scand J Clin Lab Invest. 1985;45:489-495.
15. rd ed. New York: J Wiley and Sons, Inc.; 1999.
16. Swartbol P, Truedsson L, Norgren L. Adverse reactions during endovascular treatment of aortic aneurysms may be triggered by interleukin 6 release from the thrombotic content. J Vasc Surg. 1998;28:664-668.
17. Norgren L, Swartbol P. Inflammatory response to endovascular treatment of abdominal aortic aneurysms. In: Greenhalgh RM and Powell JT, eds. Inflammatory and Thrombotic Problems in Vascular Surgery. London: WB Saunders; 1997:115-127.
18. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med. 1999;340:115-126.
19. Mehta JL, Li DY. Inflammation in ischemic heart disease: response to tissue injury or a pathogenetic villain? Cardiovasc Res. 1999;43:291-299.
20. Koukkunen H, Penttila K, Kemppainen A, et al. C-reactive protein, fibrinogen, interleukin-6 and tumour necrosis factor-alpha in the prognostic classification of unstable angina pectoris. Ann Med. 2001;33:37-47.
21. Ridker PM, Rifai N, Rose L, et al. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med. 2002;347:1557-1565.